The upcoming trials will test the drug at different doses for children as young as 6 years old who test positive for Covid-19 and are not hospitalized, but are also at risk of developing severe disease.
Related posts:
CDC panel endorses use of Pfizer Covid-19 vaccine in young teens
CDC chief said change on mask guidance not due to public pressure
Supreme Court will hear direct challenge to Roe v. Wade
CDC Director: Delta variant to ‘probably’ become dominant strain in U.S.
Covid-19 broke the CDC. Can Rochelle Walensky fix it?
Military archbishop says Catholic troops can refuse Covid vaccines on religious grounds
Confusion clouds FDA’s approach to e-cigarettes
Biden poised to nominate Califf as FDA chief
Emails reveal new details of Trump White House interference in CDC COVID planning
Dems’ plan to limit drug price inflation faces test in Senate
Moderna nears deal to pledge more vaccines to lower-income countries
Pfizer seeks emergency use authorization for Covid-19 antiviral pill
